Pluto Biosciences, Inc. — Form D
Pluto Biosciences, Inc. of Denver, CO, a company, filed a Form D exempt-offering notice with the SEC on 2021-08-17. The offering totals $1.5M, of which $1.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2021-08-17
- Form: D
- Accession: 0001877480-21-000002
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $1.0M
- Remaining: $493K
- Investors: 17
- Date of first sale: 2021-08-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-410279
Issuer
- Name: Pluto Biosciences, Inc.
- CIK: 0001877480
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 3575 Ringsby Court, Denver, CO, 80216
- Phone: 719-247-0726
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Dalton K Wright | Director | Denver, CO |
| Rani K Powers | Director | Denver, CO |
| Rani K Powers | Executive Officer | Denver, CO |
| Christopher K Glode | Director | Denver, CO |
| Mike K Dodd | Director | Denver, CO |
Other filings by this issuer (2)
More